DM
GBIO

Deerfield Management’s Generation Bio GBIO Stock Holding History

Deerfield Management’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-89,778
Closed -$25.6M – 151
2021
Q1 		$25.6M Sell
89,778
-6,344
-7% -$2.03M 0.54% 64
2020
Q4 		$27.3M Hold
96,122
– – 0.54% 61
2020
Q3 		$29.7M Sell
96,122
-22,500
-19% -$5.38M 0.72% 40
2020
Q2 		$24.9M Buy
+118,622
New +$26.4M 0.73% 43

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Deerfield Management's GBIO Position: Q2 2021 in Review

Deerfield Management sold out of Generation Bio (GBIO) in Q2 2021, closing a stake of 89,778 shares — an estimated $25.6M sold.

Deerfield Management first reported a position in GBIO in Q2 2020 and held it in 4 quarters. The position peaked at $29.7M in Q3 2020. 97 funds tracked by Wall St. Rank hold GBIO as of Q2 2021.

  • Deerfield Management reported no remaining Generation Bio position as of Q2 2021 after selling out during the quarter.
  • Deerfield Management sold 89,778 Generation Bio shares in Q2 2021, an estimated $25.6M.
  • Deerfield Management first reported a position in Generation Bio in Q2 2020 and held it in 4 quarters.
  • Deerfield Management's Generation Bio position peaked at $29.7M in Q3 2020.
  • 97 funds tracked by Wall St. Rank held Generation Bio as of Q2 2021.

Based on Deerfield Management's 13F filing for Q2 2021, filed 16 Aug 2021.